Maria R. Lamia
Naples, 80131, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Real-World Analysis of Metastatic Renal Cell Carcinoma Patients Treated with Pembrolizumab Plus Axitinib: Evidence from the Campania Oncology Network.
Journal: Current oncology (Toronto, Ont.)
Published: April 22, 2026
Bevacizumab in ovarian cancer: Clinical data and predictive and prognostic biomarkers.
Journal: Clinical and translational medicine
Published: October 03, 2025
PARPi and myeloid neoplasms; the Italian MITO-MaNGO experience based on a multicentric survey.
Journal: ESMO open
Published: August 20, 2025
The immunotherapy era in ovarian clear cell carcinoma: current evidence and future perspective.
Journal: Frontiers in immunology
Published: July 07, 2025
The emerging role of PARP inhibitors in prostate cancer: A narrative review.
Journal: Cancer treatment reviews
Published: June 16, 2025
DLL3 as a potential diagnostic and therapeutic target in neuroendocrine neoplasms: A narrative review.
Journal: Critical reviews in oncology/hematology
Published: May 08, 2024
Efficacy of PARP inhibitors in advanced high-grade serous ovarian cancer according to BRCA domain mutations and mutation type.
Journal: Frontiers in oncology
Published: April 05, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026